BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma (Q35168770)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma
scientific article

    Statements

    BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma (English)
    Patricia Rakopoulos
    Pedro Castelo-Branco

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit